Spitznagel Thomas bought MGNX
February 8, 2026 · Form 4 insider transaction
Spitznagel Thomas bought 8,999 shares of MacroGenics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,999
Price
N/A
Total value
N/A
InsiderSpitznagel Thomas
Role—
CompanyMacroGenics, Inc. (MGNX)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 8, 2026
Filing dateFebruary 10, 2026
Shares owned after33,917
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units convert into the Company's stock on a one-for-one basis.